A phase 3 open-label extension (OLE) study to evaluate the long-term safety and efficacy of ralinepag in subjects with World Health Organisation (WHO) Group 1 pulmonary arterial hypertension (PAH): ADP811-303

  • Brown, Martin (Primary Chief Investigator)
  • Butala, Radhika (Clinical Trial Unit Staff)
  • Chapman, Nicola (Clinical Trial Unit Staff)

Project: Research

Project Details

Short titleARENA 303
AcronymADVANCE-outcomes 303
StatusFinished
Effective start/end date17/10/19 → 30/06/22